Integer Holdings Shares Plunge After Customers Defer Adoption of New Products

Dow Jones
2025/10/23

By Paul Ziobro

 

Shares of Integer Holdings posted its largest single-day drop on record after the medical device company issued a downbeat outlook, citing a number of customer order updates that will dent sales.

The stock was recently down 36.3% to $69.56, putting it on pace for the largest daily decrease on record, going back to 2000. Shares are down almost 45% this year.

The Plano, Texas-based company earlier Thursday cut its outlook for this year, despite posting better-than-expected profit and revenue for the third quarter, and issued preliminary guidance for next year below Wall Street expectations.

Chief Operating Officer Payman Khales said on Thursday's earnings call that a number of customers provided updates regarding the adoption of new products that will impact the next three quarters. "The magnitude of these changes on multiple products at the same time is highly unusual," said Khales, who in April was named the company's next chief executive, an appointment effective Friday.

For the current year, Integer trimmed its outlook slightly. It now expects sales to rise 7% to 8%, versus its prior view of 8% to 9% growth, while adjusted earnings is now expected to be $6.29 to $6.43, down from $6.25 to $6.51.

For next year, Integer forecast sales between a 2% decline and 2% gain and adjusted per-share earnings to either fall up to 6% or rise up to 5%. Analysts polled by FactSet were looking for sales to rise 7.4% and adjusted earnings to increase 12.1% on a per-share basis.

The company expects that despite the slowdown next year, its strategy and product development pipeline will help restore organic sales growth that is 200 basis points above market in 2027.

 

Write to Paul Ziobro at paul.ziobro@wsj.com

 

(END) Dow Jones Newswires

October 23, 2025 10:59 ET (14:59 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10